With COVID-19 vaccine in Phase 1 trial, Novavax CEO says goal is to make 1B doses

Biotechnology company Novavax began phase one of its clinical trial for a coronavirus vaccine candidate. Novavax CEO & President Stanley Erck joins Yahoo Finance’s On The Move panel to address the company’s search for a vaccine.